Immunomedics, Inc. operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Immunomedics with three other
pharmaceutical manufacturers in North America:
sales of $3.81 million
MPX Bioceutical Corp
based in Canada
(4.38 million Canadian Dollars [US$3.52 million]
During the year ended June of 2017, sales at
Immunomedics were $3.09 million.
decrease of 4.4%
versus 2016, when the company's sales were $3.23 million.